{"id":"W1989963371","doi":"10.1002/ibd.21159","title":"Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohn's disease","year":2009,"lang":"en","type":"article","venue":"Inflammatory Bowel Diseases","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":111,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vale (Canada); St. Paul's Hospital; University of Alberta; University of Saskatchewan","funders":"","keywords":"Crohn's disease; Medicine; Internal medicine; Gastroenterology; Placebo; Double blind; Randomized controlled trial; Interleukin 23; Mesylate; Disease; Interleukin; Cytokine; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003495708,0.0006086159,0.001129051,0.0001470018,0.0001792674,0.00004381726,0.0005224039,0.0002146375,0.00003283728],"category_scores_gemma":[0.0005654217,0.0004231881,0.002127986,0.00008401975,0.0005685462,0.00003544264,0.0001050467,0.00006740954,0.000005909788],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009965516,"about_ca_system_score_gemma":0.0008691877,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006667876,"about_ca_topic_score_gemma":0.00003044907,"domain_scores_codex":[0.9966528,0.0005140213,0.001213422,0.0006533391,0.0004623812,0.0005040517],"domain_scores_gemma":[0.9970101,0.0001794208,0.0009160102,0.001116725,0.0003502161,0.0004275991],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.991421,0.00156244,0.0006821331,0.0001338755,0.0008769534,0.00007723677,0.0001451119,0.0003392872,0.003054019,0.0004844527,0.000322825,0.0009006139],"study_design_scores_gemma":[0.9655532,0.0006961913,0.01783602,0.00008456698,0.001483166,0.000001271246,0.00006348437,0.0001865748,0.0124972,0.0006426946,0.000509202,0.0004464793],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9853504,0.0005551166,0.00005771928,0.0001269761,0.0006606411,0.0123574,0.0005418003,0.00004254367,0.0003074621],"genre_scores_gemma":[0.9953591,0.0001026122,0.00003836657,0.00009988583,0.0006472995,0.002705428,0.0002213421,0.00005994679,0.0007660782],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02586791,"threshold_uncertainty_score":0.999822,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01422193391407381,"score_gpt":0.2698773401754281,"score_spread":0.2556554062613543,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}